Echottrack: A Prospective Echocardiography-Study On Participants With Heart Failure That Fit The Age-Group For Transthyretin-Amyloidosis To Track The Frequency Of Echo-Red- Flags.
Recruiting
- Conditions
- E85Amyloidosis
- Registration Number
- DRKS00033692
- Lead Sponsor
- Pfizer Pharma GmbH
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 1000
Inclusion Criteria
Signed, written informed consent
-Signs and symptoms of chronic heart failure
Exclusion Criteria
-Confirmed diagnosis of ATTR-CM (transthyretin amyloid cardiomyopathy)
-Chronic heart failure with NYHA IV classification
-Participants that are not able to sign the informed consent by themselves.
-Participants who are employees of Pfizer or the study site and their family members.
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Frequency of echocardiography-parameters typical for cardiac amyloidosis
- Secondary Outcome Measures
Name Time Method Correlation between demographic and anamnestic data with echocardiography-parameters